Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Leukemia Research|June 26, 2025
HDAC inhibitors repress Tek and Angpt1 expression and proliferation in RUNX1-MECOM-type leukemia cellsFumi Nakamura, Yuka Nakamura, Ko Sasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 3, 2026
[Long-term remission with venetoclax plus azacitidine in acute myeloid leukemia with negative conversion of FLT3 companion diagnostic testing at relapse]Satsuki Yoshihara, Takashi Toya, Tomoyuki Handa, et al.
International Journal of Hematology|April 3, 2009
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disordersKoki Ueda, Yasuhito Nannya, Keiki Kumano, et al.
Clinical and Experimental Nephrology|June 4, 2025
Long-term prognosis of pure membranous lupus nephritis: a comparison with proliferative lupus nephritis in JapanHidekazu Ikeuchi, Yoichi Imai, Shoichi Maruyama, et al.
International Journal of Hematology|September 15, 2010
CD30-positive anaplastic variant diffuse large B cell lymphoma: a rare case presented with cutaneous involvementHiroki Asano, Yoichi Imai, Satoshi Ota, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantationKeisuke Kataoka, Yasuhito Nannya, Akira Hangaishi, et al.
International Journal of Hematology|February 25, 2011
Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemiaTetsuichi Yoshizato, Yasuhito Nannya, Yumiko Yoshiki, et al.
Oncology Letters|January 7, 2022
CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemiaYuta Kaito, Mitsuhito Hirano, Muneyoshi Futami, et al.
International Journal of Hematology|June 10, 2020
Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experienceMasayuki Kobayashi, Shohei Ando, Toyotaka Kawamata, et al.
Blood|December 31, 2010
Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cellsShunya Arai, Akihide Yoshimi, Munetake Shimabe, et al.
Pageof 9